SNAI2-null mice are reported to have retarded epithelial migration rates [79], and SOX3 has been implicated in the malignant behaviour of glioblastoma [80], EMT, and in the promotion of migration and invasion of osteosarcoma cells [81,82]. This evidence concerns the gene SNAI2 and osteosarcoma.